Skip to main content

Aclaris Therapeutics, Inc.

ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001557746

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Aclaris Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
136
+17 vs. Q4 2025
Shares held
109.2M
+33.7M (+44.6%) vs. Q4 2025
Total value
$409.4M
+$182.1M (+80.1%) vs. Q4 2025
New holders
33
41 more added
Sold out
16
40 more reduced

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 136 institutions
Q1 2021: 97 institutionsQ2 2021: 128 institutionsQ3 2021: 126 institutionsQ4 2021: 133 institutionsQ1 2022: 110 institutionsQ2 2022: 115 institutionsQ3 2022: 127 institutionsQ4 2022: 128 institutionsQ1 2023: 149 institutionsQ2 2023: 133 institutionsQ3 2023: 138 institutionsQ4 2023: 107 institutionsQ1 2024: 98 institutionsQ2 2024: 98 institutionsQ3 2024: 81 institutionsQ4 2024: 98 institutionsQ1 2025: 109 institutionsQ2 2025: 96 institutionsQ3 2025: 103 institutionsQ4 2025: 122 institutionsQ1 2026: 136 institutionsQ2 2026: 148 institutions
Value heldQ1 2026: $409.4M
Q1 2021: $1.14BQ2 2021: $983.4MQ3 2021: $1.02BQ4 2021: $814.9MQ1 2022: $1.02BQ2 2022: $883.3MQ3 2022: $1.00BQ4 2022: $1.04BQ1 2023: $579.3MQ2 2023: $737.2MQ3 2023: $480.0MQ4 2023: $61.4MQ1 2024: $67.5MQ2 2024: $58.1MQ3 2024: $58.5MQ4 2024: $217.0MQ1 2025: $143.8MQ2 2025: $130.4MQ3 2025: $162.8MQ4 2025: $252.1MQ1 2026: $409.4MQ2 2026: $630.0M
Institutions holding ACRS and their total value by quarter
QuarterHoldersValue
Q2 2026148$630.0M
Q1 2026136$409.4M
Q4 2025122$252.1M
Q3 2025103$162.8M
Q2 202596$130.4M
Q1 2025109$143.8M
Q4 202498$217.0M
Q3 202481$58.5M
Q2 202498$58.1M
Q1 202498$67.5M
Q4 2023107$61.4M
Q3 2023138$480.0M
Q2 2023133$737.2M
Q1 2023149$579.3M
Q4 2022128$1.04B
Q3 2022127$1.00B
Q2 2022115$883.3M
Q1 2022110$1.02B
Q4 2021133$814.9M
Q3 2021126$1.02B
Q2 2021128$983.4M
Q1 202197$1.14B

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding ACRS in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Alliancebernstein L.P.15,200$45.8K0.00%00.0%Unchanged
Victory Capital Management Inc11,749$44.1K0.00%+1,098+10.3%Added
Simplex Trading, LLC11,216$42.1K0.00%−5,452−32.7%Reduced
Jefferies Financial Group Inc.11,000$41.3K0.00%−20.0%Reduced
Mercer Global Advisors Inc10,595$39.7K0.00%+428+4.2%Added
M&T Bank Corp10,088$37.8K0.00%+10,088New
Ameritas Investment Partners, Inc.9,267$34.8K0.00%00.0%Unchanged
Legal & General Group Plc8,242$30.9K0.00%00.0%Unchanged
Citigroup Inc7,826$29.3K0.00%−33,804−81.2%Reduced
Mirae Asset Global Investments Co., Ltd.6,290$23.6K0.00%+1,025+19.5%Added
Rockefeller Capital Management L.P.6,112$22.9K0.00%+4,886+398.5%Added
Zurcher Kantonalbank (Zurich Cantonalbank)5,006$18.8K0.00%+5,006New
California State Teachers Retirement System4,965$18.6K0.00%−684−12.1%Reduced
Tower Research Capital LLC (TRC)3,867$14.5K0.00%+117+3.1%Added
MBM Wealth Consultants, LLC3,198$12.0K0.00%+3,198New
Sterling Capital Management LLC3,037$11.4K0.00%−2,251−42.6%Reduced
GF Fund Management Co. Ltd.2,419$9.07K0.00%+291+13.7%Added
The PNC Financial Services Group, Inc.2,070$7.76K0.00%00.0%Unchanged
CWM, LLC1,358$5.09K0.00%+978+257.4%Added
GAMMA Investing LLC1,020$3.83K0.00%+791+345.4%Added
Capital Advisors, Ltd. LLC454$2.00K0.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co500$1.88K0.00%00.0%Unchanged
EverSource Wealth Advisors, LLC477$1.79K0.00%+19+4.1%Added
Farther Finance Advisors, LLC347$1.44K0.00%−51−12.8%Reduced
Parallel Advisors, LLC357$1.34K0.00%+357New
Smartleaf Asset Management LLC376$1.31K0.00%00.0%Unchanged
Nisa Investment Advisors, LLC318$1.19K0.00%00.0%Unchanged
Cornerstone Financial Management LLC270$1.01K0.00%00.0%Unchanged
Truvestments Capital LLC150$5630.00%00.0%Unchanged
SBI Securities Co., Ltd.67$2510.00%−12−15.2%Reduced
Allworth Financial LP49$1840.00%+49New
Root Financial Partners, LLC27$1010.00%+27New
Rothschild Investment LLC9$340.00%+1+12.5%Added
Essential Partners LLC5$190.00%00.0%Unchanged
MAI Capital Management1$40.00%+1New
Royal Bank of Canada88$00.00%−2,530−96.6%Reduced
Ameriprise Financial Inc0$00.00%−318,426−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−255,400−100.0%Sold out
Seven Fleet Capital Management LP0$00.00%−107,419−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−87,175−100.0%Sold out
Man Group plc0$00.00%−42,435−100.0%Sold out
Valeo Financial Advisors, LLC0$00.00%−27,540−100.0%Sold out
Jane Street Group, LLC0$00.00%−27,216−100.0%Sold out
Axq Capital, LP0$00.00%−24,186−100.0%Sold out
Persistent Asset Partners Ltd0$00.00%−22,259−100.0%Sold out
Mariner, LLC0$00.00%−16,670−100.0%Sold out
Group One Trading, L.P.0$00.00%−12,433−100.0%Sold out
R Squared Ltd0$00.00%−12,408−100.0%Sold out
Amalgamated Bank0$00.00%−2,883−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−730−100.0%Sold out
Quattro Advisors LLC0$00.00%−372−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−19−100.0%Sold out
Vanguard Group Inc––––Not filed
Kotler Kevin––––Not filed
Motiv8 Investments LLC––––Not filed